Cargando…
Beneficial Effect of Ocimum sanctum (Linn) against Monocrotaline-Induced Pulmonary Hypertension in Rats
Background: The study was designed to explore any beneficial effect of Ocimum sanctum (Linn) (OS) in experimental pulmonary hypertension (PH) in rats. OS is commonly known as “holy basil” and “Tulsi” and is used in the Indian System of Medicine as antidiabetic, antioxidant, hepatoprotective, adaptog...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6023537/ https://www.ncbi.nlm.nih.gov/pubmed/29673152 http://dx.doi.org/10.3390/medicines5020034 |
_version_ | 1783335892025344000 |
---|---|
author | Meghwani, Himanshu Prabhakar, Pankaj Mohammed, Soheb A. Dua, Pamila Seth, Sandeep Hote, Milind P. Banerjee, Sanjay K. Arava, Sudheer Ray, Ruma Maulik, Subir Kumar |
author_facet | Meghwani, Himanshu Prabhakar, Pankaj Mohammed, Soheb A. Dua, Pamila Seth, Sandeep Hote, Milind P. Banerjee, Sanjay K. Arava, Sudheer Ray, Ruma Maulik, Subir Kumar |
author_sort | Meghwani, Himanshu |
collection | PubMed |
description | Background: The study was designed to explore any beneficial effect of Ocimum sanctum (Linn) (OS) in experimental pulmonary hypertension (PH) in rats. OS is commonly known as “holy basil” and “Tulsi” and is used in the Indian System of Medicine as antidiabetic, antioxidant, hepatoprotective, adaptogenic, and cardioprotective. Methods: Monocrotaline (MCT) administration caused development of PH in rats after 28 days and rats were observed for 42 days. Treatments (sildenafil; 175 µg/kg, OS; 200 mg/kg) were started from day 29 after the development of PH and continued for 14 days. Parameters to assess the disease development and effectiveness of interventions were echocardiography, right and left ventricular systolic pressures, and right ventricular end diastolic pressure, percentage medial wall thickness (%MWT) of pulmonary artery, oxidative stress markers in lung tissue, NADPH oxidase (Nox-1) protein expression in lung, and mRNA expression of Bcl2 and Bax in right ventricular tissue. Results: OS (200 mg/kg) treatment ameliorated increased lung weight to body weight ratio, right ventricular hypertrophy, increased RVSP, and RVoTD/AoD ratio. Moreover, OS treatment decreases Nox-1 expression and increases expression of Bcl2/Bax ratio caused by MCT. Conclusion: The present study demonstrates that OS has therapeutic ability against MCT-induced PH in rat which are attributed to its antioxidant effect. The effect of OS was comparable with sildenafil. |
format | Online Article Text |
id | pubmed-6023537 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-60235372018-07-05 Beneficial Effect of Ocimum sanctum (Linn) against Monocrotaline-Induced Pulmonary Hypertension in Rats Meghwani, Himanshu Prabhakar, Pankaj Mohammed, Soheb A. Dua, Pamila Seth, Sandeep Hote, Milind P. Banerjee, Sanjay K. Arava, Sudheer Ray, Ruma Maulik, Subir Kumar Medicines (Basel) Article Background: The study was designed to explore any beneficial effect of Ocimum sanctum (Linn) (OS) in experimental pulmonary hypertension (PH) in rats. OS is commonly known as “holy basil” and “Tulsi” and is used in the Indian System of Medicine as antidiabetic, antioxidant, hepatoprotective, adaptogenic, and cardioprotective. Methods: Monocrotaline (MCT) administration caused development of PH in rats after 28 days and rats were observed for 42 days. Treatments (sildenafil; 175 µg/kg, OS; 200 mg/kg) were started from day 29 after the development of PH and continued for 14 days. Parameters to assess the disease development and effectiveness of interventions were echocardiography, right and left ventricular systolic pressures, and right ventricular end diastolic pressure, percentage medial wall thickness (%MWT) of pulmonary artery, oxidative stress markers in lung tissue, NADPH oxidase (Nox-1) protein expression in lung, and mRNA expression of Bcl2 and Bax in right ventricular tissue. Results: OS (200 mg/kg) treatment ameliorated increased lung weight to body weight ratio, right ventricular hypertrophy, increased RVSP, and RVoTD/AoD ratio. Moreover, OS treatment decreases Nox-1 expression and increases expression of Bcl2/Bax ratio caused by MCT. Conclusion: The present study demonstrates that OS has therapeutic ability against MCT-induced PH in rat which are attributed to its antioxidant effect. The effect of OS was comparable with sildenafil. MDPI 2018-04-17 /pmc/articles/PMC6023537/ /pubmed/29673152 http://dx.doi.org/10.3390/medicines5020034 Text en © 2018 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Meghwani, Himanshu Prabhakar, Pankaj Mohammed, Soheb A. Dua, Pamila Seth, Sandeep Hote, Milind P. Banerjee, Sanjay K. Arava, Sudheer Ray, Ruma Maulik, Subir Kumar Beneficial Effect of Ocimum sanctum (Linn) against Monocrotaline-Induced Pulmonary Hypertension in Rats |
title | Beneficial Effect of Ocimum sanctum (Linn) against Monocrotaline-Induced Pulmonary Hypertension in Rats |
title_full | Beneficial Effect of Ocimum sanctum (Linn) against Monocrotaline-Induced Pulmonary Hypertension in Rats |
title_fullStr | Beneficial Effect of Ocimum sanctum (Linn) against Monocrotaline-Induced Pulmonary Hypertension in Rats |
title_full_unstemmed | Beneficial Effect of Ocimum sanctum (Linn) against Monocrotaline-Induced Pulmonary Hypertension in Rats |
title_short | Beneficial Effect of Ocimum sanctum (Linn) against Monocrotaline-Induced Pulmonary Hypertension in Rats |
title_sort | beneficial effect of ocimum sanctum (linn) against monocrotaline-induced pulmonary hypertension in rats |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6023537/ https://www.ncbi.nlm.nih.gov/pubmed/29673152 http://dx.doi.org/10.3390/medicines5020034 |
work_keys_str_mv | AT meghwanihimanshu beneficialeffectofocimumsanctumlinnagainstmonocrotalineinducedpulmonaryhypertensioninrats AT prabhakarpankaj beneficialeffectofocimumsanctumlinnagainstmonocrotalineinducedpulmonaryhypertensioninrats AT mohammedsoheba beneficialeffectofocimumsanctumlinnagainstmonocrotalineinducedpulmonaryhypertensioninrats AT duapamila beneficialeffectofocimumsanctumlinnagainstmonocrotalineinducedpulmonaryhypertensioninrats AT sethsandeep beneficialeffectofocimumsanctumlinnagainstmonocrotalineinducedpulmonaryhypertensioninrats AT hotemilindp beneficialeffectofocimumsanctumlinnagainstmonocrotalineinducedpulmonaryhypertensioninrats AT banerjeesanjayk beneficialeffectofocimumsanctumlinnagainstmonocrotalineinducedpulmonaryhypertensioninrats AT aravasudheer beneficialeffectofocimumsanctumlinnagainstmonocrotalineinducedpulmonaryhypertensioninrats AT rayruma beneficialeffectofocimumsanctumlinnagainstmonocrotalineinducedpulmonaryhypertensioninrats AT mauliksubirkumar beneficialeffectofocimumsanctumlinnagainstmonocrotalineinducedpulmonaryhypertensioninrats |